Browse All

Current Filters

CLEAR FILTER x

TITLE

Five-by-Five: Nationwide Real-world Outcomes after =Five Years of Cladribine With an Age =50 Subanalysis

Author:Stastna, Dominika   Vachova, Marta   Drahota, Jiri   Potuznik, Pavel   Ampapa, Radek   Dufek, Michal   Grunermelova, Marketa   Havrdova, Eva   Houskova, Jana   Libertinova, Jana   Martinkova, Alena   Pavelek, Zbyšek   Peterka, Marek   Recmanova, Eva   Rous, Zuzana   Rous, Matous   Stetkarova, Ivana   Stourac, Pavel   Woznicova, Ivana   Horakova, Dana   Fistravec, Gregor   

Session Name:P2: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 2  

Topic:Multiple Sclerosis  

Program Number:P2.006  

Author Institution:Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia, Praha, Czech Republic  Department of Neurology, KZ a.s., Hospital Teplice, Teplice, Czechia, Teplice, Czech Republic  ReMuS, The Czech Republic Multiple Sclerosis Patient Registry, Prague, Czechia, Prague, Czech Republic  Department of Neurology, Faculty of Medicine and University Hospital in Pilsen, Charles University, Plzen, Czechia, Czech Republic  Department of Neurology, Hospital of Jihlava, Jihlava, Czechia, Jihlava, Czech Republic  First Department of Neurology, Masaryk University, St. Anne's University Hospital, Brno, Czechia, Teplice, Czech Republic  Department of Neurology, Thomayer Hospital, Prague, Czechia, Praha, Czech Republic  Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czechia, Praha 2, Czech Republic  Department of Neurology, Hospital Ceske Budejovice, Ceske Budejovice, Czechia, Borek, Czech Republic  Department of Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czechia, Praha, Czech Republic  Department of Neurology, Hospitals of the Pardubice Region, Hospital of Pardubice, Pardubice, Czechia, Pardubice, Czech Republic  Department of Neurology, Charles University in Prague, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czechia, Hradec Králové, Czech Republic  Department of Neurology, Tomas Bata Regional Hospital, Zlin, Czechia, Zlin, Czech Republic  Department of Neurology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czechia, Olomouc, Czech Republic  Charles University in Prague, Third Faculty of Medicine, Charles University and Hospital Kralovske Vinohrady, Prague, Czechia, Prague 10, Czech Republic  Department of Neurology, Masaryk University and University Hospital Brno, Brno, Czechia, Brno, Czech Republic  Department of Neurology, University Hospital Ostrava, Ostrava, Czechia, Ostrava Poruba, Czech Republic  

Is Cladribine a Suitable Strategy after Natalizumab in MS? Real-world Outcomes

Author:Vachova, Marta   Stastna, Dominika   Drahota, Jiri   Potuznik, Pavel   Ampapa, Radek   Dufek, Michal   Grunermelova, Marketa   Kubala Havrdova, Eva   Houskova, Jana   Hradilek, Pavel   Libertinova, Jana   Martinkova, Alena   Pavelek, Zbysek   Peterka, Marek   Recmanova, Eva   Rous, Matous   Rous, Zuzana   Stetkarova, Ivana   Stourac, Pavel   Horakova, Dana   Fistravec, Gregor   

Session Name:P4: Multiple Sclerosis: Health Services/Outcomes Research and Real-world Evidence 4  

Topic:Multiple Sclerosis  

Program Number:P4.007  

Author Institution:KZ a.s., Hospital Teplice, Teplice, Czech Republic  General University Hospital in Prague, Czech Republic  ReMuS Registry, Prague, Czech Republic  Faculty of medicine and University Hospital in Pilsen, Czech Republic  Neurologicka Klinika Jihlava, Jihlava, Czech Republic  Masaryk University, St.Annes University Hospital, Czech Republic  Thomayer Hospital, Praha, Czech Republic  Hospital Ceske Budejovice, , Czech Republic  University Hospital Ostrava, Czech Republic  2nd Faculty of Medicine, Charles University in Prague and Motol, Praha, Czech Republic  Hospitals of the Pardubice Region, Pardubice, Czech Republic  Charles University in Prague, Faculty of Medicine and University Hospital Hradec Kralove, Czech Republic  Tomas Bata Regional Hospital, Zlin, Czech Republic  Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic  Charles University, Third Faculty of Medicine, Department of University, Prague 10, Czech Republic  University Hospital Brno, Neurology Clinic, Brno, Czech Republic  General University Hospital in Prague, Prague, Czech Republic  Registr ReMuS, Prague, Czech Republic  

Efficacy and Safety of Frexalimab in Participants With Relapsing Multiple Sclerosis: 3-Year Results From the Phase 2 Open-label Extension

Author:Vermersch, Patrick   Krieger, Stephen   Wiendl, Heinz   Granziera, Cristina   Mao-Draayer, Yang   Cutter, Gary   Kalbus, Oleksandr   Staikov, Ivan   Dufek, Michal   Montalban, Xavier   Saubadu, Stephane   Luo, Xiaodong   Smyth, Brendan   Djukic, Biljana   Truffinet, Philippe   Wallstroem, Erik   Giovannoni, Gavin   

Session Name:P7: Multiple Sclerosis: Clinical Trials 1  

Topic:Multiple Sclerosis  

Program Number:P7.003  

Author Institution:University of Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France, Lille, France  Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, NY, United States, New York, NY  Department of Neurology and Neurophysiology, University of Freiburg, Freiburg, Germany  Brain & Mind Institute, University of Sydney, Sydney, Australia, Freiburg im Breisgau, Germany  Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine  Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, Basel, Switzerland  Autoimmunity Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States, Oklahoma City, OK  Department of Biostatistics, UAB School of Public Health, Birmingham, AL, United States, Birmingham, AL  Department of Neurology, Dnipro State Medical University, Dnipro, Ukraine, Dnipro, Ukraine  Clinic of Neurology and Sleep Medicine, Acibadem City Clinic University Hospital Tokuda, Sofia, Bulgaria, Sofia, Bulgaria  First Department of Neurology, St. Anne’s University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic, Brno, Czech Republic  Multiple Sclerosis Centre of Catalonia, Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain , Barcelona, Spain  Sanofi, Gentilly, France, Chilly Mazarin, France  Sanofi, Morristown, NJ, United States, Morristown, NJ  Sanofi, Cambridge, MA, United States, Cambridge, MA  Queen Mary University of London, London, United Kingdom, London, United Kingdom